Predictive factors for prognosis of hilar cholangiocarcinoma: Postresection radiotherapy improves survival

European Journal of Surgical Oncology

Volumn 33, Issue 2, 2007, Pages 202-207

  Cheng, Q ^a   Luo, X ^a   Zhang, B ^a   Jiang, X ^a   Yi, B ^a   Wu, M ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Cholangiocarcinoma; Prognosis; Radiotherapy

Indexed keywords

BILIRUBIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER HILUS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURGICAL TECHNIQUE; SURVIVAL RATE; UNIVARIATE ANALYSIS;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHINA; CHOLANGIOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 33847354781     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.09.033     Document Type: Article

References (27)

1. Vauthey J.N., and Blumgart L.H. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 14 (1994) 109-114
2. Nakeeb A., Pitt H.A., Sohn T.A., et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224 (1996) 463-473
3. Rea D.J., Munoz-Juarez M., Farnell M.B., et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 139 (2004) 514-525
4. Neuhaus P., Jonas S., Bechstein W.O., et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 230 (1999) 808-819
5. Klempnauer J., Ridder G.J., von Wasielewski R., et al. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 15 (1997) 947-954
6. Jarnagin W.R., Fong Y., DeMatteo R.P., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234 (2001) 507-517
7. Iwatsuki S., Todo S., Marsh J.W., et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 187 (1998) 358-364
8. Todoroki T., Kawamoto T., Koike N., et al. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 87 (2000) 306-313
9. Bismuth H., Nakache R., and Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215 (1992) 31-38
10. Tsao J.I., Nimura Y., Kamiya J., et al. Management of hilar cholangiocarcinoma, comparison of an American and a Japanese experience. Ann Surg 232 (2000) 166-174
11. Hemming A.W., Reed A.I., Fujita S., et al. Surgical management of hilar cholangiocarcinoma. Ann Surg 241 (2005) 693-702
12. Miyazaki M., Ito H., Nakagawa K., et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?. Surgery 123 (1998) 131-136
13. Pitt H.A., Nakeeb A., Abrams R.A., et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 221 (1995) 788-798
14. Gerhards M.F., van Gulik T.M., Gonzalez Gonzalez D., et al. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 27 (2003) 173-179
15. Sagawa N., Kondo S., Morikawa T., et al. Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg Today 35 (2005) 548-552
16. Takada T., Amano H., Yasuda H., et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95 (2002) 1685-1695
17. Figueras J., Llado L., Valls C., et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 6 (2000) 786-794
18. Wolfsen H.C. Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus. J Clin Gastroenterol 39 (2005) 653-664
19. Burger I., Hong K., Schulick R., et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16 (2005) 353-361
20. Chiou Y.Y., Hwang J.I., Chou Y.H., et al. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J Med Sci 21 (2005) 304-309
21. Molt P., Hopfan S., Watson R.C., et al. lntraluminal radiation therapy in the management of malignant biliary obstruction. Cancer 57 (1986) 536-544
22. Urego M., Flickinger J.C., and Carr B.I. Radiotherapy and multimodality management of cholangiocarcinoma. Int J Radiat Oncol Biol Phys 44 (1999) 121-126
23. Tashiro S., Tsuji T., Kanemitsu K., et al. Prolongation of survival for carcinoma at the hepatic duct confluence. Surgery 113 (1993) 270-278
24. Vallis K.A., Benjamin I.S., Munro A.J., et al. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability. Radiother Oncol 41 (1996) 61-66
25. Gonzalez Gonzalez D., Gouma D.J., Rauws E.A., et al. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol 10 (1999) 215-220
26. Kamada T., Saitou H., Takamura A., et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys 34 (1996) 767-774
27. Todoroki T. Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology 47 (2000) 644-649